The development history of Wuhan Zhongyuan Ruide Biological Products Co., Ltd. is a microcosm of the integration and upgrading of China's blood products industry. From a research institute with a military background to a joint holding company of domestic and foreign enterprises, then through full ownership by the overseas capital CSL Behring, and ultimately being brought under the umbrella of Tiantan Biological. This series of changes profoundly reflects the trajectory of integration and upgrading in China's blood products industry. Looking ahead, against the backdrop of continuous accumulation of blood product technology, Wuhan Zhongyuan Ruide Biological Products Co., Ltd. is expected to occupy a more prominent position in the domestic blood products market after deep integration with central enterprise resources, and continue to promote China's blood products industry to break through import dependence and safeguard national biosafety.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows